🚀 VC round data is live in beta, check it out!
Ortoma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ortoma and similar public comparables like Diagnostic Medical Systems, Mentice, Nortech Systems, Acarix and more.
Ortoma Overview
About Ortoma
Ortoma AB is engaged in development of products and solutions for orthopedic and joint implant surgeries.
Founded
2001
HQ
Employees
5
Website
Sectors
Financials (LTM)
EV
$37M
Ortoma Financials
Ortoma reported last 12-month revenue of $7M and negative EBITDA of ($1M).
In the same LTM period, Ortoma generated $5M in gross profit, ($1M) in EBITDA losses, and had net loss of ($3M).
Revenue (LTM)
Ortoma P&L
In the most recent fiscal year, Ortoma reported revenue of $7M and EBITDA of ($473K).
Ortoma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $7M | XXX | $7M | XXX | XXX | XXX |
| Gross Profit | $5M | XXX | $6M | XXX | XXX | XXX |
| Gross Margin | 72% | XXX | 82% | XXX | XXX | XXX |
| EBITDA | ($1M) | XXX | ($473K) | XXX | XXX | XXX |
| EBITDA Margin | (16%) | XXX | (7%) | XXX | XXX | XXX |
| EBIT Margin | (38%) | XXX | (30%) | XXX | XXX | XXX |
| Net Profit | ($3M) | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | (37%) | XXX | (29%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Ortoma Stock Performance
Ortoma has current market cap of $39M, and enterprise value of $37M.
Market Cap Evolution
Ortoma's stock price is $1.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $37M | $39M | 0.3% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOrtoma Valuation Multiples
Ortoma trades at 5.0x EV/Revenue multiple, and (31.6x) EV/EBITDA.
EV / Revenue (LTM)
Ortoma Financial Valuation Multiples
As of April 20, 2026, Ortoma has market cap of $39M and EV of $37M.
Equity research analysts estimate Ortoma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ortoma has a P/E ratio of (14.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $39M | XXX | $39M | XXX | XXX | XXX |
| EV (current) | $37M | XXX | $37M | XXX | XXX | XXX |
| EV/Revenue | 5.0x | XXX | 5.2x | XXX | XXX | XXX |
| EV/EBITDA | (31.6x) | XXX | (78.3x) | XXX | XXX | XXX |
| EV/EBIT | (13.1x) | XXX | (17.4x) | XXX | XXX | XXX |
| EV/Gross Profit | 7.0x | XXX | 6.3x | XXX | XXX | XXX |
| P/E | (14.3x) | XXX | (18.8x) | XXX | XXX | XXX |
| EV/FCF | (32.4x) | XXX | 111.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ortoma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Ortoma Margins & Growth Rates
Ortoma's revenue in the last 12 month grew by 32%.
Ortoma's revenue per employee in the last FY averaged $1.4M, while opex per employee averaged $1.6M for the same period.
Ortoma's rule of 40 is (19%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ortoma's rule of X is 1% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Ortoma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 32% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | (16%) | XXX | (7%) | XXX | XXX | XXX |
| EBITDA Growth | 63% | XXX | 456% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (19%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 1% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.6M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 22% | XXX | 23% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 111% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Ortoma Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ortoma | XXX | XXX | XXX | XXX | XXX | XXX |
| Diagnostic Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Mentice | XXX | XXX | XXX | XXX | XXX | XXX |
| Nortech Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Acarix | XXX | XXX | XXX | XXX | XXX | XXX |
| Mauna Kea Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ortoma M&A Activity
Ortoma acquired XXX companies to date.
Last acquisition by Ortoma was on XXXXXXXX, XXXXX. Ortoma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Ortoma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOrtoma Investment Activity
Ortoma invested in XXX companies to date.
Ortoma made its latest investment on XXXXXXXX, XXXXX. Ortoma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Ortoma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ortoma
| When was Ortoma founded? | Ortoma was founded in 2001. |
| Where is Ortoma headquartered? | Ortoma is headquartered in Sweden. |
| How many employees does Ortoma have? | As of today, Ortoma has over 5 employees. |
| Is Ortoma publicly listed? | Yes, Ortoma is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Ortoma? | Ortoma trades under ORT B ticker. |
| When did Ortoma go public? | Ortoma went public in 2023. |
| Who are competitors of Ortoma? | Ortoma main competitors are Diagnostic Medical Systems, Mentice, Nortech Systems, Acarix. |
| What is the current market cap of Ortoma? | Ortoma's current market cap is $39M. |
| What is the current revenue of Ortoma? | Ortoma's last 12 months revenue is $7M. |
| What is the current revenue growth of Ortoma? | Ortoma revenue growth (NTM/LTM) is 32%. |
| What is the current EV/Revenue multiple of Ortoma? | Current revenue multiple of Ortoma is 5.0x. |
| Is Ortoma profitable? | No, Ortoma is not profitable. |
| What is the current EBITDA of Ortoma? | Ortoma has negative EBITDA and is not profitable. |
| What is Ortoma's EBITDA margin? | Ortoma's last 12 months EBITDA margin is (16%). |
| What is the current EV/EBITDA multiple of Ortoma? | Current EBITDA multiple of Ortoma is (31.6x). |
| What is the current FCF of Ortoma? | Ortoma's last 12 months FCF is ($1M). |
| What is Ortoma's FCF margin? | Ortoma's last 12 months FCF margin is (15%). |
| What is the current EV/FCF multiple of Ortoma? | Current FCF multiple of Ortoma is (32.4x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.